FMP

FMP

Enter

Amgen Shares Surge 12% Following Positive Obesity Drug Update

-

twitterlinkedinfacebook
blog post cover photo

Image credit: FMP

Amgen (NASDAQ:AMGN) announced on Thursday that it will discontinue its experimental weight-loss pill to focus on its injectable drug, MariTide, and other obesity-related developments. Jay Bradner, Amgen’s Chief Scientific Officer, explained during an earnings call that the company has decided to cease further development of the oral drug based on its performance and instead channel resources into MariTide and other preclinical projects.

Following this announcement, Amgen's shares jumped over 12% intra-day today. The injectable treatment, MariTide, is currently in a mid-stage trial for obese or overweight adults who do not have diabetes. Amgen plans to release initial data from this trial later this year, and Bradner expressed satisfaction with the preliminary results.

In addition, Amgen is collaborating with regulatory agencies to plan a late-stage trial for MariTide and has also announced a second-stage trial aimed at evaluating the drug's effectiveness in treating diabetes.

Other Blogs

May 27, 2024 3:30 PM - Rajnish Katharotiya

The best 5 GPU stocks other than NVDA

In the ever-evolving world of technology, certain sectors have consistently demonstrated exceptional growth and innovation. The graphics processing units (GPUs) industry is one such sector, offering investors a golden opportunity for potentially high returns. In this blog, we'll delve into why inves...

blog post title

Jun 6, 2024 2:47 AM - Parth Sanghvi

ROE vs ROA: Which Metric is More Important for Investors?

ROE vs. ROA: Which Metric is More Important for Investors? When evaluating a company's financial performance, investors often rely on various metrics to gauge profitability and efficiency. Two commonly discussed metrics are Return on Equity (ROE) and Return on Assets (ROA). Understanding the diff...

blog post title

Jun 6, 2024 2:57 AM - Parth Sanghvi

DCF vs NPV: Which Valuation Method Should You Use?

When it comes to valuing an investment or a business, two of the most commonly used methods are Discounted Cash Flow (DCF) and Net Present Value (NPV). Both methods are essential tools in finance, but they serve slightly different purposes and are used in different contexts. This guide will explore ...

blog post title
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep